We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

Automation of Multiplexed Cell-Based Viability and Cytotoxicity Assays Scientific Poster



Andrew Niles, Tracy Worzella and Michael Busch1
Promega Corporation, 2800 Woods Hollow Rd., Madison, WI 53711
1CyBio AG, Goeschwitzer Strasse 40, 07745 Jena, Germany 

Promega has developed homogeneous, non-lytic reagents that measure the proportion of viable and non-viable cells in the same assay well. Here we demonstrate the use of automation to perform highthroughput and ultra-high throughput cell-based multiplexing studies. We provide protocols and supporting data that demonstrate the automation synergies of the assays with the CyBio CyBi®-Well hardware. We show that complementary viability and cytotoxicity measures have particular merit for normalizing data to reduce error associated with cell clumping or identifying errors from interferences due to test compounds or medium components. In addition, we also demonstrate how the MultiTox assays can be further multiplexed with a downstream assay, such as a Promega luminescent assay or other spectrally distinct fluorescent assay method, to measure caspase activation, reporter activity, or cell viability. Specifically, we show how these novel assays can be further multiplexed with downstream apoptosis assays in order to determine mode of action effects.

Document Icon Download the poster PDF (142kb)

  • Part# PS070
  • Printed in USA.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.